Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
414
NCT03879928
A SAD, MAD, and FE Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of FM101 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 8, 2019
Completion: May 1, 2020
NCT04585100
FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension
Phase: Phase 1/2
Start: Oct 7, 2020
Completion: Jun 30, 2023
NCT04710524
FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
Phase: Phase 2
Start: Jun 10, 2021
Completion: Aug 31, 2023
NCT05223166
A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA
Phase: Phase 3
Start: Apr 12, 2022
Completion: Jul 18, 2023